Pay in 4 interest-free payments of $6.88 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
When comparing immunoreactivity observed on tissue microarrays slides with that of the WTS slides, only 1/40 (3%) MPNST tumor was found to demonstrate discordant (status of 'partial loss' with 20% of loss of staining on TMA and status of 'intact/retained' with 5/10% of loss of staining on the WTS slides)
These trials have been kind of a bust, Standaert says
Neither is FDA-approved for human use, and neither is available as a prescription therapy
See our BPC-157 vs TB-500 comparison for protocol context on each compound
US$ 29.07
)
US$ 21.58
US$ 21.63
US$ 20.14
US$ 24.14
US$ 22.81
